Possible Bene ts With Combined Creatinine and cystatin C Test for Estimated GFR by Hedberg, Tobias
Bachelor thesis: Possible Benefits With
Combined Creatinine and cystatin C Test for
Estimated GFR
Tobias Hedberg
June 5, 2015
1
Contents
1 Introduction 3
1.1 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Aim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.3 Previous Research . . . . . . . . . . . . . . . . . . . . . . . . . 3
2 Medical Background 4
2.1 The Kidney . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.2 Glomerular Filtration Rate (GFR) . . . . . . . . . . . . . . . 4
2.3 Creatinine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.4 Cystatin C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
3 Material 7
4 Design of Statistical Model 8
5 Estimations of Model Parameters 13
6 Optimisation of Decision 15
7 Monte-Carlo Analysis on Test Results 16
8 Discussion and Conclusions 18
8.1 Caveats . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
References 19
2
1 Introduction
1.1 Background
When seeking medical care creatinine is used as an indicator for kidney mal-
function in many different contexts and is measured as concentrations in
blood tests. Creatinine levels are roughly proportional to the rate at which
blood is filtered through the kidnies into primary urine. This rate can also
be called glomerular filtration rate (GFR) and is used to predict the level
of treatment needed in patients with kidney dysfunction. The benefits with
creatinine is a widely available analysis were results return in a timely fash-
ion. However, the level of creatinine is affected by factors in addition to GFR
such as muscle mass, blood volume, sex and age [1]. Because of this, interest
has been raised for a protein called cystatin C which provides a more exact
estimate of GFR, but is costlier.
Because kidney decease is more common and relevant to patients of older
age groups only patients with an age higher than 65 are being considered in
this thesis. Additionally Sweden has an average life time expectancy which
is rising [2], which creates an economical dilemma as well.
1.2 Aim
The goal of this thesis is to research possible benefits with a combined creati-
nine and cystatin C test compared to only a creatinine test when estimating
a patient’s GFR.
1.3 Previous Research
A lot of research has been made on the kidneys and their functions and
quite a large amount of models to estimate GFR have been presented, such
as creatinine combined with cystatin C [3]. Not much about uncertainty
of diagnosis in the diagnostic threshold areas of GFR has been researched,
however. Placing a patient on the right side of a chronic kidney disease
(CKD) grading line is essential to providing proper treatment, which is why
this thesis has focused almost exclusively on this matter.
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2 Medical Background
2.1 The Kidney
Normally a human has one pair of kidneys in their bodies. Located at the
lowest pair of the ribs, next to the spine in the rear part of the abdominal
cavity. They have the shape of a bean and size of a human fist. The kidneys
play an important role in our body and make sure a lot of waste products
and unwanted substances gets filtrated out of our body.
The kidney is provided with a steady flow of blood through one, or up
to three, afferent (carrying inwards) arteries from the aorta. Their sizes can
vary individually among the arteries in each kidney and as a note it can be
added that this is important for deciding whether two patients are a match for
transplantation or not. The kidneys works like a filtration unit in the body
and consists of a network of capillaries that follows the afferent arteries and is
called the glomerulus. Further on this blood is transferred through the organ
in arteries of decreasing size. These carry blood into the smallest functioning
unit of the kidney, the nephron. A partition of the blood, roughly equivalent
to its plasma, exits the blood vessel into the Bowman capsule, which is the
first part of the nephron. From here, the plasma, or primary urine, travels
up and down the kidney in a tubule where it is continually concentrated
through a series of ion channel and concentration gradient activities. The
total accumulated rate at which plasma exits into the millions of Bowman
capsules in both kidneys is the GFR. Blood moves on from the capsule after
releasing some of its plasma in an efferent arteriole carrying it to a capillary
network on the outside of the tubules where it supplies the nephrones with
nutrients and oxygen. It then combines in bigger and bigger veins carrying
it back to the heart, while the concentrated urine exits the kidneys into the
ureters to the urinary bladder and onwards. [1]
2.2 Glomerular Filtration Rate (GFR)
The filtration of unwanted or high levels of different substances is situated
in the above mentioned glomerulus. Filtration rate is measured in mL/min
and in Figure 1 the values of the different stages of a kidney’s health is
graphically described with red (0-15 mL/min), yellow (15-60 mL/min) and
green (larger than 60 mL/min) [4]. Firstly,the red area represents patients
with end stage renal decease, henceforth refereed to as ESRD. This is a
serious diagnosis to get, you are likely to begin dialysis and the risk for
death is severe. Secondly, the yellow area represents patients with chronic
kidney decease, henceforth refereed to as CKD. This is a diagnosis where
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the treatment usually is dietary changes and take an increasing number of
medicines as decease progresses. Lastly, the green area represents healthy
patients or patients with a temporarily slightly decreased kidney function.
Figure 1: GFR values representing different stages of the kidneys’ health.
Red indicating 0-15 mL/min, yellow indicating 15-60 mL/min and lastly
green indicating larger than 60 mL/min [4].
2.3 Creatinine
Creatinine is a waste product from the muscles in our bodies and has no role
in our body. It is formed when creatinine phosphate, or phosphocreatine,
is worn down. Phosphocreatine is quickly released during the first seconds
when the body needs to move rapidly.
Creatinine levels are measured routinely by a blood test as an indicator of
general health because early kidney decease lacks clear symptomatology and
a great number of deceases and substances affect kidney function. Creatinine
analysis has been proven a good method for estimating the care seeker’s
kidney’s health, through GFR. As GFR decreases creatinine rises as a result
of decreasing clearance. The level of creatinine in the blood is dependent on
the constitution of one’s body, to be more precise, the muscle mass. A high
value is stating that something might be wrong, but if you have an athletic
body and thus a lot of muscle mass, this value might be just all right [5]. The
price for a creatinine test is 9 SEK in the county of Sk˚ane at the university
hospitals [6].
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2.4 Cystatin C
In contrast to creatinine cystatin C is not dependent on the muscle mass and
thus more reliable. Cystatin C is a protein and can be found in all of the
human body’s cells and its main function is to maintain and regulate the
activity of some protein degrading enzymes [5]. However a cystatin C test is
much more expensive than a creatinine test. The cost varies from county to
county. As a reference the price for a cystatin C test is 24 SEK in the county
of Sk˚ane at the university hospitals [6].
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3 Material
The material used in this thesis is collected from the research behind the
article in Scandinavian Journal of Clinical and Laboratory Investigation [3].
They measured iohexol clearance (mL/min/1.73m2) in 857 patients and com-
pared it to the formulas described further down in this thesis, equation (1)
and (2). The data set consisted of both female (44%) and male (56%) pa-
tients from the cities Lund and Malmo¨, Sweden. Their age, sex, weight,
length were also measured and included in the data set. The earlier work
tried to figure out a formula without the weight parameter and therefore they
came up with the formulas presented under the next segment in this thesis.
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4 Design of Statistical Model
Human bodies are very complex and scientists still discover new areas to do
further research on. To estimate and conclude different values in the body it
would be far to complicated and expensive to measure all imaginable values
to conclude a diagnosis for a potentially ill patient. This is why a medical
doctor tries to narrow it down to just a couple of tests. As provided in the
section above, a blood test is the fastest way to approximate the kidneys
health status. Every test is only accurate to a certain point and this is why
a statistical model should be considered. In this thesis the creatinine (pCr)
will be indexed K and the combined test, with both creatinine and cystatin
C (pCyC), will be indexed C.
In the formerly referred article in Scandinavian Journal of Clinical and
Laboratory Investigation (SJCLI) two formulas for estimating GFR were
presented with either creatinine (pCr) referred to in equation (1), or a com-
bination of creatinine and cystatin C (pCyC) shown in equation (2). [3]
GFR = eX−0.0124·age·0.339·ln(age)−0.226·(if female) (1)
where X is defined as
X = 4.621− 0.0112 · pCr if pCr<150 µmol/L
X = 8.17 + 0.0005 · pCr− 1.07 · ln(pCr) if pCr≥150 µmol/L
GFR = eX−0.718·ln(pCyC)−0.00452·age+0.0549·ln(age)−0.153·(if female) (2)
where X is defined as
X = 5.02− 0.00716 · pCr if pCr<150 µmol/L
X = 7.07 + 0.0004 · pCr− 0.636 · ln(pCr) if pCr≥150 µmol/L
To start off, a model for creatinine will be formulated and explained first,
followed by a combined model with both creatinine and cystatin C. The aim
is to see if there are possible benefits of taking a second test (cystatin C),
after the creatinine test. The second test might then give a better picture of
the patients kidney status. Based on the results from the first (creatinine)
test the goal with the following segments and sections are to conclude if one
can decide whether the doctors decision will be better by doing a second test.
The simplest model would be a direct relationship between GFR and
creatinine, like the one in equation (3) where f(K) is equal to equation (1).
GFR = f(K) (3)
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In Figure 2 the relationship between GFR is estimated by the level of
creatinine with the formula in equation (1). If a comparison is made with
Figure 3, where the actual values of the GFR and their correlated creatinine
levels are presented, a clear relationship can be seen. In Figure 3 the blue
markers represents female patients and the orange markers represents male
patients.
Figure 2: GFR model from SJCLI[3].
Figure 3: GFR versus creatinine.the blue markers represents female patients
and the orange markers represents male patients.
Since the body is such a complex structure it is more true to life to have
a relationship where the relationship is as in equation (4), where the value
of GFR is an expected value. Because this is not a linear proportionality a
deterministic prediction of exact GFR cannot be made. This is reflected in
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Figure 4: Normal probability plot for ξK .
a clinical context by the fact that more weight is attached to a significant
change of creatinine levels in subsequent analyses than is given to a single
analysis alone.
〈GFR〉 = f(K) (4)
With the body being as complex as it is and the model having a level of
uncertainty the ξ-term is added to the formula, as seen in equation (5). This
is a term consisting of the standard deviation multiplied with , which is a
random variable and it is N(0, σ) distributed.
GFR = f(K) + ξK (5)
The properties of ξK is as displayed below. In Figure 4 the normal prob-
ability plot for ξK can be seen and a good approximation is that ξK is taken
from a normal distribution.
〈ξK〉 = 0 〈ξ2K〉 = σ2K (6)
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Figure 5: Actual GFR versus f(K)
When actual GFR and GFR estimated by the formula in equation (1)
is plotted against each other the conclusion can be drawn that they have a
heteroscedastic relationship and this is shown in Figure 5. This means that
the variation is increasing with larger values of GFR. By doing a logarithmic
transformation of these functions the variation is now homoscedastic and
more suitable to make further studies on. The new representation of the
relationship is presented in Figure 6.
11
Figure 6: Logarithmic plot for ln(GFR) versus ln(fK).
The function for the correlation between the logarithmic forms of f(K)
and GFR is then estimated, displayed as equation (7). This estimation of the
parameters and variables, and all to follow, is further explained in section 5.
lnGFR = αK + βK ln(f(K)) + ξK (7)
The above procedure is then made in the very same way as above, but
with the only difference in that now the function f(K) is replaced by f(C),
which is equation (2). This combined test is now represented by the final
equation (8). The newly introduced variables αC , βC and σC are determined
in the same procedure as for creatinine and will be further explained how
they were estimated in section 5.
lnGFR = αC + βCf(C) + ξC (8)
The benefit with a combined test is that the test’s accuracy will increase
significantly since it is based on two separate test, especially since the cystatin
C is independent of body mass. Since f(C) uses creatinine in its formula
they are also dependent on each other. This is verified by plotting ξK and
ξC against each other and this is shown in Figure 7.
Since these are both normally distributed these form a bi-variate distri-
bution with three variables; σK the standard variation of creatinine, σC the
standard variation of the combined test and ρ the correlation coefficient for
the bivariate distribution.
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Figure 7: Correlation between ξK and ξC .
5 Estimations of Model Parameters
Why is a parametrical model necessary; why could not the data be used
directly? The reason for this is the number of data points in the provided
data. Since the given number of patients is definite (857 patients), a model
is the only suitable solution. The limits to what can be described by the
model is the validity of the original model, in this case the f(K) and f(C).
And it has been proven very satisfactory in the article in SJCLI [3].
GFR depends of the parameters of f(K), which are levels of creatinine,
age and sex. The likelihood function (L) is proportional to the conditional
probability of any given GFR provided the values of said parameters. This
leads to the proportionality in equation (9)
L ∝ P (GFRi | Ki, agei, sexi) (9)
Using the Maximum Likelihood method to estimate the parameters of
this statistical model, the product of all probabilities the total probability is
calculated according to equation (10).
L =
N∏
i=1
P (GFRi | Ki, agei, sexi) (10)
Furthermore the natural logarithm of L is taken and this results in equa-
tion (11).
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l = ln(L) =
N∑
i=1
ln(P (GFRi | Ki, agei, sexi)) (11)
To estimate the parameters introduced (αK , αC , βK , βC , σK , σC and ρ)
in the previous section a scheme for estimating all the parameters was made.
A good way to optimize the parameters without creating a biased estimator
is to use the Nelder-Mead method [7]. This method works great if a good
initial value is provided. These values were calculated in a five-step scheme
presented below.
• αK and βK ,
– By plotting ln(GFR) against ln(f(K)) and taking the mean value
of αK and βK based on the function in equation (7).
• σK and thereby ξK ,
– By subtracting and thus calculate the residual from: ln(GFR) −
αK − βK · ln(fK) = resK
• αC and βC ,
– By plotting ln(GFR) against ln(f(C)) and taking the mean value
of αC and βC based on the function in equation (8).
• σC and thereby ξC ,
– By subtracting and thus calculate the residual from: ln(GFR) −
αC − βC · ln(fC) = resC
• Correlation coefficient ρ.
– By plotting the residual from creatinine and the residual from
cystatin C and taking the mean value of the coefficient.
After the five steps explained above an initial value was provided and put
into this method, the Nedler-Mead method, which is also a built-in function
in MATLAB and named fminsearch [7].
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6 Optimisation of Decision
Since the cost of the treatment from one diagnosis to another varies a lot,
the decision was made to eliminate the cost from the analysis and only take
into consideration when someone might receive wrong treatment based on
the (GFR) test results. If the patient receives the right treatment it might
be at a cost for the state or the hospital but the cost is strictly relevant to
the diagnosis and not an unnecessary additional cost where the money could
be better spent on something else.
The qualitative goal with optimisation of the decision is to help the doc-
tors determine the right diagnosis or treatment when suspecting kidney mal-
function by testing the GFR. The quantitative goal with this section is to
minimize the probability of an incorrect diagnosis and therefore maximize
the probability of giving the right treatment.
A creatinine test costs less than a cystatin C analysis and the creatinine
test is done as a routine when suspecting kidney malfunction and the cystatin
C is used when a more precise and more accurate value of the GFR is desired.
Consequently one can ask the question; when is it necessary or beneficial to
do another test (cystatin C)? This will be covered and explained in this
section and in the sections to follow.
As mentioned in section 2, three kinds of diagnosis are to chose from,
ESRD, CKD and healthy. To optimize the decision three conditional proba-
bilities were created as seen in equation (12a),(12b) and (12c). These proba-
bilities determines how probable it is to have one of the three diagnoses given
the test result from the creatinine test.
Probabilities for different diagnoses:
P (ESRD | f(K)), (12a)
P (CKD | f(K)), (12b)
P (Healthy | f(K)). (12c)
With these probabilities the right diagnosis and treatment accordingly is
the one with the largest probability. By plotting the probability for wrongly
treating a patient against GFR based on creatinine test gives the results as
shown i Figure 8
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Figure 8: Probability of misdiagnosing patients as a function of creatinine
analysis results (GFR).
7 Monte-Carlo Analysis on Test Results
If the probability for misdiagnosing the patient is called Pwrong and the prob-
ability of doing so, after an extra test, the combined cystatin C test, is called
P ∗wrong. The relationships between these test will be as in equation (13) since
cystatin C tests are more precise[8].
Pwrong ≥ P ∗wrong (13)
This does not mean that every decision based on the latter test are better
than a decision made from only the first test, this is just the probability
for giving the patient the wrong treatment based on their actual kidney’s
health. When is it beneficial for a doctor to prescribe the combined test? If
the difference between the probabilities is very small there is no need for an
extra test, since it may not be worth the extra cost.
With the now known value of the estimated GFR (f(K)) the bivariate
distribution for ξC [9] as displayed in equation (14) was used to calculate
the probability for a value of f(C). This was done by using equation (7)
to calculate ln(GFR) and by inserting this into equation (8) and thus the
only term left unknown is f(C), which is then calculated.  is drawn from a
standard normal distribution.
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ξC = ρσC
ξK
σK
+
√
1− ρ2σC (14)
By sampling from the GFR distribution (creatinine-based) where every sam-
ple now has its unique, known GFR value it is possible to use a Monte-Carlo
method to sample from the distribution, and by using the method explained
in section 6 f(K) is replaced by f(C). The fraction of incorrect decisions is
estimated for each case. This new probability is then plotted against GFR,
as shown in Figure 9.
Figure 9: Probability plot for wrongly treating patients based on a creatinine
(blue) and a combined (green) test.
In this figure one can see that the probability for wrongly diagnosing
patients is very much the same for creatinine (marked as blue in the figure)
and the combined test (marked as green in the figure), except for values
close to the borders between the different kidney’ statuses. In these areas
the probabilities for mistreating patients are significantly reduced. Notice
that the values are only estimates since they are constructed by sampling,
but the estimation error is rather small, as can be seen by the statistical
noise in the graph.
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8 Discussion and Conclusions
This thesis was constructed from the models in equation (1) and equation
(2). This relationship is given as a formula relating measurements to the
GFR value, but does not account for uncertainty in the estimation, hence
the goal was to explicitly account for statistical variations.
The approach was changed from a cost perspective on estimating GFR
to the perspective of minimizing the probabilities of misdiagnosing a patient,
based on the results from the blood test. To know the exact GFR is seldom
of greater importance to a doctor, what’s of great value is to determine the
correct diagnosis. The relevant quantity to minimize is the cost the incorrect
decisions might give rise to. However, since such measure are very hard
to estimate, it was therefore decided to instead focus on fraction of correct
decision, since such variable is easy to compute in the model.
To determine if it is effective to also measure cystatin C, the fraction of
correct decision concerning treatment of the patient was compared using a
Monte-Carlo procedure. The conclusions from this report there are potential
benefits of using this clinically in different hospitals in Sweden since it might
be very cost effective in using cystatin C tests only when applicable from
Figure 9.
8.1 Caveats
The raw data of 857 patients and their age, sex, cystatin C, creatinine and
their actual GFR value was received from the writers of the article in Scan-
dinavian Journal of Clinical and Laboratory Investigation [3]. This data,
used in the current thesis, is not completely representative for the entire
population of Sweden, since patients with kidney dysfunction is overly rep-
resentative.
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